Zusammenfassung
Neuromodulation bezeichnet die gezielte, chronische und steuerbare Einflussnahme auf neuronale Prozesse mit dem Ziel, therapeutische Wirkungen zu erzeugen. Ein Paradebeispiel von Neuromodulation ist die tiefe Hirnstimulation (THS). THS wird am häufigsten für Bewegungsstörungen eingesetzt, zunehmend aber auch für weitere neurologische und psychiatrische Erkrankungen. Dieser Beitrag führt in die Grundlagen der Neuromodulation und die Kriterien für deren ethische Bewertung ein. Danach werden aktuelle klinische und ethische Fragen von Neuromodulation am Beispiel der THS erläutert. Der Beitrag schließt mit Empfehlungen für Forschung und klinische Weiterentwicklung von THS und anderen Methoden der Neuromodulation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Aebi-Müller R (2014) Der urteilsunfähige Patient – eine zivilrechtliche Auslegeordnung. Jusletter 22, September 2014. Zugänglich unter: http://jusletter.weblaw.ch/juslissues/2014/771.htmlprint
Ambermoon P, Carter A, Hall WD et al (2011) Impulse control disorders in patients with Parkinson’s disease receiving dopamine replacement therapy: evidence and implications for the addictions field. Addiction 106(2): 283–293
Beauchamp TL, Childress JF (2013) Principles of biomedical ethics, 7th edn. Oxford University Press, Oxford
Benabid AL, Pollak P, Louveau A, Henry S, de Rougemont J (1987) Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. Appl Neurophysiol 50: 344–346
Benabid AL, Chabardes S, Mitrofanis J, Pollak P (2009) Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson’s disease. Lancet Neurol 8: 67–81
Blomstedt P, Sjöberg RL, Hansson M et al (2013) Deep brain stimulation in the treatment of obsessive-compulsive disorder. World Neurosurg 80(6): e245–53
Boccard SG, Pereira EA, Aziz TZ (2015) Deep brain stimulation for chronic pain. J Clin Neurosci 22(10): 1537–1543
Chopra A, Klassen BT, Stead M (2013) Current clinical application of deep-brain stimulation for essential tremor. Neuropsychiatr Dis Treat 9: 1859–1865
Christen M, Müller S (2012) Current status and future challenges of deep brain stimulation in Switzerland. Swiss Med Weekly 142: w13570
Christen M, Bittlinger M, Walter H et al (2012) Dealing with side effects of deep brain stimulation: lessons learned from stimulating the STN. AJOB Neurosci 3(1):37–43
Christen M, Ineichen C, Tanner C (2014a) How »moral« are the principles of biomedical ethics? A cross-domain evaluation of the common morality hypothesis. BMC Med Ethics 15: 47
Christen M, Ineichen C, Bittlinger M, Bothe H-W, Müller S (2014b) Ethical focal points in the international practice of deep brain stimulation. AJOB Neurosci 5(4): 65–80
Christen M, Müller S (2015) Effects of brain lesions on moral agency: ethical dilemmas in investigating moral behavior. In: Ohl F, Lee G, Illes J (eds) Ethical issues in behavioural neuroscience. Current topics in behavioral neuroscience 19. Springer, Berlin Heidelberg New York, S 159–188
Fisher RS, Velasco AL (2014) Electrical brain stimulation for epilepsy. Nat Rev Neurol 10(5):261–270
Hariz MI, Blomstedt P, Zrinzo L (2010) Deep brain stimulation between 1947 and 1987: the untold story. Neurosurg Focus 29(2): E1
Hariz M, Blomstedt P, Zrinzo L (2013) Future of brain stimulation: new targets, new indications, new technology. Mov Disord 28(13): 1784–1792
Holsheimer J (2003) Letters to the editor. Neuromodulation 6(4): 270–273
Krames EF, Peckham PH, Rezai AR (eds) (2009) Neuromodulation. Academic Press, London
McIntyre CC, Chaturvedi A, Shamir RR, Lempka SF (2015) Engineering the next generation of clinical deep brain stimulation technology. Brain Stimul 8(1): 21–26
Mosley PE, Marsh R, Carter A (2015) Deep brain stimulation for depression: scientific issues and future directions. Aust N Z J Psychiatry 49(11): 967–978
Müller S, Christen M (2011) Deep brain stimulation in Parkinsonian patients – ethical evaluation of stimulation-induced personality alterations. AJOB Neurosci 2(1): 3–13
Müller S, Walter H, Christen M (2014) When benefitting a patient increases the risk for harm for third persons – the case of treating pedophilic Parkinsonian patients with deep brain stimulation. Int J Law Psychiatry 37: 295–303
Odekerken VJ, van Laar T, Staal MJ et al (2013) Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson’s disease (NSTAPS study): a randomised controlled trial. Lancet Neurol 12(1): 37–44
Schläpfer TE, Fins JJ (2010) Deep brain stimulation and the neuroethics of responsible publishing: when one is not enough. JAMA 303(8): 775–776
Schrock LE, Mink JW, Woods DW et al (2015) Tourette syndrome deep brain stimulation: a review and updated recommendations. Mov Disord 30(4): 448–471
Schüpbach WM, Rau J, Knudsen K et al (EARLYSTIM Study Group) (2013) Neurostimulation for Parkinson’s disease with early motor complications. N Engl J Med 368(7): 610–622
Schüpbach WM, Agid Y (2008) Psychosocial adjustment after deep brain stimulation in Parkinson’s disease. Nat Clin Pract Neurol 4(2): 58–59
Siegfried J (1986) Effect of stimulation of the sensory nucleus of the thalamus on dyskinesia and spasticity. Rev Neurol (Paris) 142(4): 380–383
Udupa K, Bahl N, Ni Z et al (2016) Cortical plasticity induction by pairing subthalamic nucleus deep-brain stimulation and primary motor cortical transcranial magnetic stimulation in Parkinson’s disease. J Neurosci 36(2): 396–404
Vidailhet M, Jutras MF, Grabli D, Roze E (2013) Deep brain stimulation for dystonia. J Neurol, Neurosurg Psychiatry 84(9): 1029–1042
Wächter T, Mínguez-Castellanos A, Valldeoriola F et al (2011) A tool to improve pre-selection for deep brain stimulation in patients with Parkinson’s disease. J Neurol 258(4): 641–646
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer-Verlag GmbH Deutschland
About this chapter
Cite this chapter
Christen, M. (2017). Klinische und ethische Fragen der Neuromodulation. In: Erbguth, F., Jox, R. (eds) Angewandte Ethik in der Neuromedizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-49916-0_11
Download citation
DOI: https://doi.org/10.1007/978-3-662-49916-0_11
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-49915-3
Online ISBN: 978-3-662-49916-0
eBook Packages: Medicine (German Language)